<DOC>
	<DOCNO>NCT00448955</DOCNO>
	<brief_summary>Male hypogonadism , disorder associate testosterone deficiency , frequently see clinical practice significant effect patient wellbeing . The purpose study investigate efficacy safety ARD-0403 testosterone replacement therapy testosterone deficient men .</brief_summary>
	<brief_title>Open-Label Study ARD-0403 Testosterone Deficient Men</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Testosterone deficiency Previous treatment testosterone replacement therapy within 4 week Moderatesevere benign prostatic hypertrophy , prostatic cancer Haematocrit &gt; 50 %</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>